AJA Life Sciences Advisory LLC provides independent, physician-executive-led advisory focused on judgment, decision framing, and leadership advisory to life sciences organizations advancing therapeutics, diagnostics, and precision medicine navigating complex strategic, clinical, and portfolio decisions.
Twelve advisory domains. Each grounded in operating excellence, delivered at the senior-most level.
Strategic decision framing and prioritization. Independent perspective on complex issues. Board and executive-level advisory. Support during inflection points.
Portfolio prioritization and resource allocation. Pipeline strategy and lifecycle planning. Risk-benefit and investment decision support. Alignment of clinical, strategic, and commercial priorities.
Clinical-commercial alignment. Translational pathways from development to market. Adoption and scalability. Integration of evidence into market strategy.
Real-world evidence (RWE) strategy. HEOR frameworks. Investigator-initiated studies. Product evaluation and validation strategies.
Publication strategy. Congress and scientific engagement. Medical education strategy. Alignment with strategic objectives.
Key Opinion Leader identification, mapping, and engagement. Scientific advisory boards. Medical society engagement. Guideline development.
MA/CA structure and operating models. KPIs/Budget systems. Cross-functional alignment. Capability development.
Medical and clinical training and education of internal and external stakeholders. Tailored learning journeys.
Workflow optimization. Accreditation support. Lean Six Sigma frameworks. Alignment of lab performance with outcomes.
Define where and how your solution fits within care pathways, aligns with therapeutic strategy, and advances innovation—while enabling real-world clinical adoption.
Partnership evaluation. Strategic fit assessment. Deal strategy. Cross-functional alignment.
Portfolio company advisory. Clinical and scientific diligence. Growth strategy. Diagnostics and MedTech investment evaluation.
Partnering with biopharma and diagnostics leaders across the full product lifecycle.
Defining the strategic foundation, target positioning, and investment thesis from the earliest stages.
Stage 1Designing evidence generation strategies, clinical studies, and RWE frameworks that build the value story.
Stage 2Aligning clinical, commercial, and market access strategies for a coordinated and impactful launch.
Stage 3Driving clinical adoption, stakeholder engagement, and value demonstration in the market.
Stage 4Optimizing outcomes, lifecycle management, and sustained evidence generation post-launch.
Stage 5Engagement structures designed for leaders who need direct, senior-level advisory—not layers of process.
Ongoing strategic advisory with direct, retained access to senior advisory at the C-suite and board level.
RetainedFocused, high-impact advisory sessions designed for critical decision windows and inflection points.
IntensiveFormal advisory roles on boards, scientific committees, and investor advisory panels.
Advisory RoleEmbedded, senior-level leadership for organizations in transition or building critical capabilities.
LeadershipRapid-turnaround advisory for specific questions, diligence calls, or preparation for high-stakes moments.
On-DemandDefined-scope engagements with clear deliverables, timelines, and outcomes for targeted strategic needs including product launch activities, clinical programs, and regulatory & clinical compliance.
Project-BasedStrategic guidance for organizations entering new geographies, including market assessment, stakeholder mapping, and go-to-market planning.
GlobalWe engage when the stakes are highest and the decisions are most consequential.
Critical moments in portfolio strategy, pipeline progression, or investment decisions that demand independent, experienced advisory.
Organizational shifts, leadership changes, or market pivots that require a steady, experienced hand to navigate uncertainty.
Situations where clinical evidence, commercial strategy, and enterprise value must be aligned into a coherent path forward.
Due diligence, strategic fit assessment, and deal evaluation where deep domain expertise is essential.
When internal consensus isn’t enough and you need a trusted, independent voice with real operating experience.
Driving efficiency, governance, and scalable operating models across medical affairs and commercial organizations. From strategy through implementation.
AJA Life Sciences Advisory works with a limited number of clients to ensure depth, focus, and confidentiality. If you're navigating a high-stakes decision, we'd welcome the conversation.